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THE DISTRIBUTION AND SIGNIFICANCE OF ANTICOAGULANT-RESIST ANT 
NORWAY RA TS (RAITUS NORVEGICUS) IN ENGLAND AND WALES, 1988-95 
ALAND. MACNICOLL, GERARD M. KERINS, NICOLA J. DENNIS, and J. ERICA GILL, Central Science 
Laboratory, Ministry of Agriculture, Fisheries and Food, London Road, Slough, Berkshire, SL3 7HJ, United Kingdom. 
ABSTRACT: Between 1988 and 1995 populations of rats on agricultural premises were sampled to investigate the 
distribution of anticoagulant-resistant rats in England and Wales. In total, approximately 1,670 rats from 115 locations 
were tested for resistance to warfarin. Rats that were warfarin-resistant were subsequently tested for resistance to 
difenacoum, and since 1991 for resistance to bromadiolone. In some cases rats were also tested for resistance to 
brodifacoum, and in 1995 for resistance to flocoumafen. The results of these tests showed that there was a high 
prevalence of resistance to the first-generation anticoagulant, warfarin, in several regions of England and Wales. Rats 
from most populations sampled since 1991 appeared to be more resistant to bromadiolone than difenacoum, but in central 
southern England there were some populations where the reverse was true. In this same part of the country there was 
a relatively small focus where the rats had high degrees of resistance to several anticoagulant rodenticides. There was 
little evidence of resistance to brodifacoum or flocoumafen. The data are discussed with respect to the impact of 
anticoagulant rodenticide resistance on control of rats in the United Kingdom. 
KEY WORDS: anticoagulants, brodifacoum, bromadiolone, commensal rodents, difenacoum, flocoumafen, laboratory 
testing, Muridae, Norway rats, rats, resistance, Rodentia, rodenticides, rodents, U.K., vertebrate pest control, warfarin 
INTRODUCTION 
Norway rats (Rattus norvegicus) resistant to the 
anticoagulant rodenticide warfarin were first discovered 
on a pig farm in Scotland in 1958 (Boyle 1960). 
Subsequently, populations of rats resistant to warfarin and 
other first-generation anticoagulant rodenticides were 
discovered in Denmark (Lund 1964), England and Wales 
(Drummond and Bentley 1967), Germany (Telle 1967), 
Holland (Ophof and Langeveld 1969), the United States 
of America (U.S.A.)(Jackson and Kaukeinen 1972) and 
Italy (Alessandroni et al. 1980). A second generation of 
anticoagulant rodenticides was developed (reviewed by 
Hadler and Buckle 1992) to overcome the control 
problems caused by resistance to the first-generation 
compounds. The newer anticoagulants such as 
bromadiolone and difenacoum were based on the same 
chemical structure and mode of action as warfarin. With 
the benefit of hindsight, it is not surprising that resistance 
was discovered within a few years of the first commercial 
use of difenacoum (Redfern and Gill 1978). Further 
studies (Greaves et al. 1982) indicated a significant and 
widespread incidence of difenacoum-resistant rats across 
an area of central southern England with a history of 
warfarin resistance in rats. Populations of rats that 
included individuals resistant" to bromadiolone have been 
reported in Denmark (Lund 1981), Holland (Van 
Blaaderen and Bode 1989) and Germany (Pelz et al. 
1995). Responses to a questionnaire indicated that 
laboratory tests have identified populations of Norway rats 
in Denmark, France, Germany and the United Kingdom 
(U.K.) that were resistant to one or more anticoagulant 
rodenticides (Myllymaki 1995). That same report 
indicated that Rattus norvegicus trapped and tested in 
Finland were susceptible to anticoagulant rodenticides. 
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Proc. 17th Vertebr. Pest Conf. (R.M. Timm & A.C. Crabb, 
Eds.) Published at Univ. of Calif .• Davis. 1996. 
The authors' laboratory has been funded by the U.K. 
Ministry of Agriculture, Fisheries and Food to investigate 
the occurrence and significance of anticoagulant-resistant 
rats in England and Wales. Historical data (Drummond 
1966; Greaves 1970; MacNicoll and Gill 1987) indicated 
that warfarin-resistant rats predominated in most rat 
populations in Wales and the bordering English counties, 
southeast England, central southern England, and central 
Scotland (Figure 1). The present paper reports the results 
of tests carried out between 1988 and 1995 for resistance 
to warfarin, difenacoum, brodifacoum, bromadiolone 
(1991 to 1995 only) and flocoumafen (1995 only). 
Sampling of rat populations was based largely on reports 
of poor or unsuccessful control using anticoagulant 
rodenticides, and is, therefore, biased towards detection 
of anticoagulant-resistant rats. In addition, samples of 
some rat populations were tested for anticoagulant 
resistance prior to field studies designed to investigate the 
causes of control failure (Quy et al. 1992a, 1992b, 1994; 
Cowan et al. 1995). 
METHODS 
Animals 
Rats were sampled from infestations on agricultural 
premises using single-capture live traps, and transported 
to the laboratory. They were treated with insecticide to 
reduce ectoparasite infestation, and housed singly in 
suspended wire cages. They were fed rat and mouse No. 
1 low vitamin K ( < 1 mg/kg of vitamin K) pelleted diet 
(SDS Ltd., Witham, Essex, U.K.) ad libitum, and 
provided free access to water containing 100 mg/L of 
menadione sodium bisulphite (MSB; Sigma Chemical 
Co. , Poole, Dorset, U.K.) to prevent vitamin K 
deficiency. 
Figure 1. Location of populations of warfarin-resistant rats in 
the U.K. 1958 to 1987. 
Testing for Anticoagulant Resistance 
Between 1988 and 1991, warfarin resistance status 
was determined using the method of Martin et al. (1979). 
From 1992 onwards a revised method was used, which 
incorp9rated several refinements (MacNicoll and Gill 
1993). Animals that were warfarin-resistant were, after 
a gap of at least one week, tested for resistance to 
difenacoum. Warfarin-susceptible rats were not usually 
subjected to further tests for anticoagulant resistance. 
In 1988 and 1989, resistance to difenacoum was 
determined by survival of a five-day feeding test using 
0.0053 (w/w) difenacoum (Redfern and Gill 1978), and 
since 1990 by blood clotting response (BCR) four days 
after administration of a sub-lethal dose of difenacoum 
(Gill et al. 1993). From 1991 onwards warfarin-resistant 
rats were tested for resistance to bromadiolone by BCR 
test (Gill et al. 1994). There were gaps of at least three 
weeks between sequential tests for resistance to 
second-generation anticoagulants on the same animal. 
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Difenacoum (or bromadiolone from 1991 onwards) 
resistant rats were subjected to a seven-day feeding test 
using 0.00053 (w/w) brodifacoum in the diet (Gill and 
MacNicoll 1991). Rats that survived for more than three 
weeks after the end of the feeding regime had at least a 
low degree of resistance to brodifacoum. 
In 1995 rats that had a degree of resistance to 
difenacoum and/or bromadiolone were tested for 
resistance to flocoumafen. Full details of this test will be 
published elsewhere. Flocoumafen (0.6 mg/kg body 
weight) was administered by oral intubation in 
conjunction with 10 mg/kg body weight of MSB. 
Proteolytic activity of blood clotting Factor X was 
measured four days later, and rats with greater than 0.1 
units of Factor X per ml of plasma were classified as 
flocoumafen-resistant. Factor X levels in control animals 
were approximately 0.5 units per ml of plasma. 
Mapping of Anticoagulant Resistance in England and 
Wales 
---:rhe grid reference for each farm where rats were 
trapped between 1988 and 1995 was recorded. The 
results of warfarin resistance tests were used to determine 
whether < 103, 10 to 903, or >903 of rats sampled 
from each location were warfarin-resistant. This 
information was entered, together with grid references, 
into a software package (DMAP for Windows, Alan 
Morton, Imperial College, London, U.K.) to provide the 
distribution map shown in Figure 2. 
• > 90% of Rats Warfarin-Reslstant 
0 10 • 90'Y. of Rats Warfarln·Reslstant 
0 < 10% of Rats Warfarin-Reslstant 
Figure 2. Location of rat populations sampled between 1988 
and 1995 and tested for resistance to warfarin. 
Figure 3a was produced in a similar manner, but each 
site sampled in 1988 and 1989 was categorized on the 
basis of < 103, IO to 503, or >503 of rats in each 
sample surviving a difenacoum feeding test. Figure 3b 
shows the results from 1990 to 1995, but in this case 
farms were categorized on the basis that the mean 
percentage clotting activity (PCA) on day 4 of BCR tests 
for difenacoum resistance was < I03, IO to 503, or 
> 503 of activity measured at the time of difenacoum 
administration. 
Figure 4 plots the distribution of brodifacoum 
resistance based on survival of a feeding test. Each 
location was categorized on the same basis as survival of 
a difenacoum feeding test in Figure 3a. The results of 
BCR tests for bromadiolone resistance between 1991 and 
1995 were categorized on the same basis as for 
difenacoum resistance in Figure 3b, and are presented in 
Figure 5. 
RESULTS AND DISCUSSION 
W arfarin Resistance 
Figure 2 summarizes the results of warfarin resistance 
tests carried out on 1,670 rats trapped on 115 farms 
between 1988 and 1995. The symbol at each location 
indicates that < I03 (30 farms; open circles), between IO 
and 903 (38 farms; shaded circles), or >903 (45 farms; 
filled circles) of the sample were warfarin-resistant. 
These groups were selected to highlight populations that 
contained few, if any, warfarin-resistant rats, and those 
where use of anticoagulant rodenticides had selected 
populations that included few, if any, susceptible rats. 
This enables identification of areas where warfarin (and 
other first-generation anticoagulant rodenticides) could be 
successfully used for control of rats because of the 
predominance of warfarin susceptibility. Conversely, 
predominance of warfarin-resistant rats indicates that the 
first-generation compounds would probably not be 
effective. Some success may be achievable in control of 
intermediate populations using warf arin, but the likelihood 
of further selection of higher degrees of anticoagulant 
resistance should influence the choice of active ingredient 
used. 
It can be seen from Figure 2 that there are large areas 
of the U .K. where we have not sampled rat populations 
for warfarin resistance testing. Since the survey has been 
largely responsive to reports of rat control problems, and 
relies on the presence of relatively large infestations of 
rats, it is suggested that first-generation anticoagulants, 
such as warfarin, can be successfully used for control of 
rats on agricultural premises in more than 503 of the 
land area of England and Wales. Neither the authors' 
laboratory, nor any other organization, has routinely 
sampled rats from urban areas in the U .K. for the 
purposes of resistance testing. Reports of rat control 
problems in urban areas are not routinely investigated, 
and only two samples of rats have been subjected to 
laboratory tests for resistance. It is, therefore, difficult to 
comment on whether anticoagulant resistance is currently 
a serious problem in urban areas of the U .K. 
The data in Figure 2 show, however, that many 
populations of rats in rural areas of central southern and 
southeast England included significant numbers of 
warfarin-resistant individuals. It is also interesting to note 
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that some samples of rat populations that included 
warfarin-resistant individuals were from locations (Figure 
2) remote from the known foci of resistance (Figure I). 
This may indicate that warfarin-resistant rats have been 
transported to those farms from other parts of the 
country. Alternatively, warfarin-resistant rats may have 
been common in neighboring populations, but effective 
control was achieved with second-generation anticoagulant 
rodenticides and problems were not, therefore, reported. 
Difenacoum Resistance 
The results of testing 909 warfarin-resistant rats for 
resistance to difenacoum between 1988 and 1995 are 
shown in Figure 3. In 1988 and 1989 difenacoum 
resistance was determined by survival of a feeding test 
(Redfern and Gill 1978), and the results in Figure 3a for 
11 locations (183 rats) are grouped on the principle that 
<IO 3 (3 farms; open circles), IO to 503 (7 farms; 
shaded circles), or > 503 (1 farm; filled circles) of rats 
survived. 
The new BCR test for difenacoum resistance (Gill et 
al. 1993) used from 1990 onwards had a number of 
advantages over the feeding test, including the possibility 
of testing difenacoum-susceptible animals for resistance to 
bromadiolone and other anticoagulants. The authors have 
grouped the results for 79 locations shown in Figure 3b 
into those samples where the mean PCA value of all 
(warfarin- resistant) rats tested was < 103 (23 farms; 
open circles), between IO to 503 (35 farms; shaded 
circles), and >503 (21 farms; filled circles). The data 
presented by Gill et al. (1993) showed that rats with PCA 
values of < I03 on day 4 after administration of 
difenacoum were unlikely to survive feeding on 0.0053 
(w/w) difenacoum for five days, and that when PCA 
values were 503 then >503 and >703 of male and 
female rats survived, respectively. Using mean PCA 
values for population samples can be criticized on the 
grounds that BCR may not have been normally distributed 
within the sample, and the mean values were not, 
therefore, wholly representative. The only method to 
fully illustrate the data would be to use histograms of the 
results of BCR tests on rats from each location. Mean 
PCA values do, however, reflect the distribution of BCR 
within the sample. By dividing the samples into three 
broad categories the authors believe that this is the best 
means of concisely presenting the data. Thus, the three 
categories illustrated in Figure 3b could be considered as 
locations where difenacoum-susceptible rats 
predominated, where some rats in the population had a 
low degree of resistance to difenacoum, or where they 
had a high degree of resistance to difenacoum. 
Difenacoum-resistant rats were first identified in 
central southern England (Redfern and Gill 1978; Greaves 
et al. 1982), and it was from this area that rats were 
sampled which had the highest degrees of difenacoum 
resistance. Several factors have been identified (Quy et 
al. 1992a, 1992b) that may have detrimental effects on 
control of rats on farms in central southern England, but 
there is evidence of selection pressure favoring 
difenacoum-resistant rats (Cowan et al. 1995). That same 
report also concluded that control of these rats with 
difenacoum did not represent a practical problem, 
although that was based on trials carried out on farms 
,• 
• > 50% of Rats Dlfenacoum-Reslstant 
0 10 • 50% of Rats Dlfenacoum-Reslstant 
0<10% of Rats Dlfenacoum-Reslstant 
a 
Figure 3a. Location of rat populations sampled between 1988 
and 1989 and tested for resistance to difenacown by feeding 
0.005 (w/w) difenacoum for five days (Redfern and Gill 1978). 
e > 50% of Rats Brodlfacoum-Reslstant 
0 10 • 50% of Rats Brodlfacoum-Reslstant 
0 < 10% of Rats Brodlfacoum-Reslstant 
Figure 4. Location of rat populations sampled between 1988 
and 1995 and tested for resistance to brodifacown. 
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e Mean PCA > 50%, Dlfenacoum-Realstant 
0 Mean PCA 10 • 50%, Dlfenacoum-Realstant 
0 Mean PCA < 10%, Dlfenacoum-Suaceptlble 
b 
Figure 3b. Location of rat populations sampled between 1990 
and 1995 and tested for resistance to difenacoum by blood 
clotting response to sub-lethal dose of difenacown (Gill et al. 
1993). 
• Mean PCA > 50%, Bromadlolone-Reslstant 
0 Mean PCA 10 • 50%, Bromadlolone-Reslstant 
0 Mean PCA < 10%, Bromadlolone-Susceptlble 
Figure 5. Location of rat populations sampled between 1991 
and 1995 and tested for resistance to bromadiolone. 
with rat populations within the category of a low degree 
of resistance to difenacoum. Figure 3b indicates that rats 
with the highest degrees of resistance to difenacoum were 
in the north of this area, where resistance may have a 
greater influence on the outcome of rat control on farms. 
Outside of central southern England it would appear that 
rats on agricultural premises are susceptible, or at worst 
have only a low degree of resistance, to difenacoum. 
Brodifacourn Resistance 
The data presented in Figure 4 summarize the results 
of brodifacoum resistance testing of 462 difenacourn or 
bromadiolone-resistant rats in 41 samples of farm rat 
populations trapped between 1988 and 1995. The results 
were categorized as < 103 (37 farms; open circles), or 
10 to 503 (4 farms; shaded circles) of rats surviving a 
brodifacoum resistance feeding test. 
Figure 4 shows that samples from most farms 
contained < 103 of individuals that were resistant to 
brodifacoum, even though those rats were difenacourn or 
bromadiolone-resistant, indicating that infestations should 
be successfully controlled with brodifacourn. Significant 
numbers of brodifacoum-resistant rats were only detected 
on four farms in a relatively small area of central 
southern England. Unfortunately, the authors have not 
been able to carry out field trials with brodifacoum in that 
area, and cannot assess the impact of an apparently low 
degree of brodifacoum resistance on control success or 
failure. 
Bromadiolone Resistance 
Between 1991 and 1995, approximately 600 warfarin-
resistant rats were tested for bromadiolone resistance 
using a BCR test (Gill et al. 1994). The samples of rats 
from 41 locations shown in Figure 5 were categorized as 
described above for Figure 3b, i.e., locations where the 
mean PCA value for the sample was < 10% (1 farm; 
open circles, bromadiolone-susceptible), between 10 to 
503 (11 farms; shaded circles, a low degree of 
bromadiolone resistance), and > 503 (29 farms; filled 
circles, a high degree of bromadiolone resistance). 
This is the first time that widespread sampling of rats 
has been carried out in the U.K. for the purpose of 
bromadiolone resistance testing. The data in Figure 5 
show that warfarin-resistant rats trapped from populations 
in different parts of England and Wales also had high 
degrees and/or high prevalence of resistance to 
bromadiolone. The population of bromadiolone-
susceptible rats sampled in west Wales were the warfarin-
susceptible rats tested to validate the BCR test (Gill et al. 
1994). In central southern England some samples of rats 
were categorized as including rats with a low degree of 
bromadiolone resistance. This corresponds to locations 
where the rats also bad low degrees of resistance to 
difenacoum. 
A field trial on a heavily rat-infested farm in central 
southern England showed that a 23-day control program 
using surplus baiting with 0.005% (w/w) bromadiolone 
had little impact on the size of the population (Quy et al. 
1995). Rats that bad survived this treatment were 
sampled by trapping, and bait label analysis indicated that 
51 % (n=63) bad eaten more than 100 g of bait. 
Laboratory tests showed that the rats bad a high degree of 
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resistance to bromadiolone, and it was concluded (Quy et 
al. 1995) that the study provided the first unequivocal 
demonstration of control failure with a multiple-feed 
second-generation anticoagulant that was attributable to 
resistance. The BCR of rats sampled from farms within 
a few miles of the study site indicated that they also had 
high degrees of resistance to bromadiolone, which 
suggests that it may also have been difficult to control rats 
on neighboring farms with bromadiolone. 
Flocoumafen Resistance 
Use of a new BCR test for flocoumafen resistance 
began in 1995. Of the 159 difenacoum and/or 
bromadiolone-resistant rats from 14 locations tested for 
flocoumafen resistance, only two samples, from central 
southern England, included rats that had resistance to 
flocoumafen. In one sample only 1/9 rats tested had a 
low degree of resistance to flocoumaf en. All six female 
rats and 3/ 10 male rats tested from a second farm 
apparently had significant degrees of resistance to 
flocoumafen. 
Cross-resistance to More Than One Anticoagulant 
Rodenticide 
The testing regime used in the laboratory begins with. 
testing for resistance to warfarin, as a representative of 
the first-generation anticoagulant rodenticides. The 
results of many studies over the last 20 years have shown 
that warfarin-susceptible rats are susceptible to the whole 
group of anticoagulant rodenticides. The results 
presented in this paper indicate that 273 (21179) and 71 3 
(29/41) of populations of warfarin-resistant rats sampled 
included rats that had high degrees of resistance to 
difenacoum or bromadiolone, respectively. 
Only 12 samples from central southern England (e.g. , 
the study site used by Quy et al. 1995) included rats that 
had a high degree of resistance to both difenacoum and 
bromadiolone. Some of those rats also had a low degree 
of resistance to brodifacoum. Apart from in this small 
area, it should be possible to achieve control of 
warfarin-resistant rats using difenacoum or bromadiolone 
as appropriate, especially where the rats have only a low 
degree of resistance to these rodenticides. Nevertheless, 
the possibility of selecting higher degrees of resistance to 
anticoagulants should not be ignored. 
Although there is no published test for resistance to 
diphacinone, 11 warfarin-resistant rats were tested in one 
sample from central southern England by feeding 0.005 3 
(w/w) diphacinone for five days without alternative food. 
Ten of the rats survived more than three weeks after the 
end of the feeding period, each having eaten more than 
85 g of the diet containing diphacinone. The farmer had 
been using a bait containing the same concentration of 
diphacinone in an attempt to control rats on his farm, but 
the authors' results indicate that those attempts were 
unlikely to be successful. 
• 
Temporal Changes 
Although the authors' laboratory has been monitoring 
resistance to anticoagulant rodenticides in England and 
Wales for 30 years, it is not possible to make significant 
conclusions on temporal changes. Most apparent changes 
in resistance status arise following the introduction of a 
new compound, application of a new test or sampling of 
rats from a new area. Early studies indicated that 
migration of warfarin-resistant rats, and continued 
selection, resulted in an apparent radial distribution of 
three miles per year from a focus of resistance 
(Drummond 1966). If the results of the present study are 
compared to earlier reports (Greaves et al . 1982), it is 
clear that the already extensive distribution of 
difenacoum-resistant rats in central southern England bas 
not increased by three miles a year in any direction over 
the last 12 to 15 years. Studies are in progress to assess 
the deleterious effects of anticoagulant resistance genes on 
the fitness of rats in this area, which may help explain 
why they have not apparently spread further afield. 
Alternatively, there may be ecological factors in the area 
that favor large rat infestations requiring frequent control 
with anticoagulant rodenticides, which causes heavy 
selection pressure towards anticoagulant resistance. 
Future Work 
In 1995 the authors' changed their tactic for selection 
of rat populations to be sampled up to 1998. Rather than 
responding to reports of control problems, the aim was to 
sample rat populations in areas of England and Wales not 
extensively sampled in the past. Because previous results 
indicated that anticoagulant-resistant rats were found most 
frequently on pig or poultry farms, the authors 
preferentially selected those types of farms for sampling. 
Early results from 1995 showed that warfarin-resistant 
rats were present on one farm in south-west England, and 
on one farm in the east. The small number of rats 
trapped on these two farms (two and three, respectively) 
indicated that the populations were small, and that there 
were not serious control problems. Testing for resistance 
to second-generation anticoagulants has not been 
completed. 
The results of a survey between 1995 and 1998 will 
provide further insight into the distribution and 
significance of anticoagulant resistance in the U .K. 
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